Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of ...

The data were featured in an oral presentation at the American Diabetes Association (ADA) annual conference in Chicago as part of the symposium, “Innovation and Progress in Stem Cell-Derived ...